Rating History for Moleculin Biotech (MBRX) by Maxim Group

More Stocks Rated by Maxim Group | Latest Ratings for MBRX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
3/25/2025 Jason McCarthy Upgrade Buy
(Hold)		 4.00
(N/A)		 1.06
(2.08)		 96.23% Details